ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 22158597

Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?

Netto GJ. Nat Rev Urol, 2011. Cited by 98 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet? Papers, record 22158597. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22158597

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
PubMed
Journal
Nat Rev Urol
PubMed
Year
2011
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
98
iCite
Relative citation ratio, by iCite
2.81
iCite
Revised in PubMed
2021-10-21
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Netto GJGeorge J

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Urinary Bladder NeoplasmsMajor topic
Animals
Biomarkers
Humans
Signal Transduction

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References147

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116,517,112Raf1, Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma; a retrospective TMA study of 246 patients with long-term follow-up.Eur J Surg Oncol2006https://conductscience.org/library/papers/16517112PubMed
218,047,954Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.Urol Oncol2007https://conductscience.org/library/papers/18047954PubMed
320,553,211The origins of urothelial carcinoma.Expert Rev Anticancer Ther2010https://conductscience.org/library/papers/20553211PubMed
417,256,055Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis.J Clin Invest2007https://conductscience.org/library/papers/17256055PubMed
516,753,364Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria.J Urol2006https://conductscience.org/library/papers/16753364PubMed
615,082,203Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).Eur Urol2004https://conductscience.org/library/papers/15082203PubMed
716,288,222Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls.Oncogene2006https://conductscience.org/library/papers/16288222PubMed
816,732,887Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.BMC Cancer2006https://conductscience.org/library/papers/16732887PubMed
912,509,763Targeting RAS signalling pathways in cancer therapy.Nat Rev Cancer2003https://conductscience.org/library/papers/12509763PubMed
1019,168,670A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102.Ann Oncol2009https://conductscience.org/library/papers/19168670PubMed

1 to 10 of 147

See all 147 references

Cited by64

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.

PMIDTitleJournalYearIn PapersSource
41,561,769
Integrative bulk and single-cell transcriptomic analysis reveals COL1A2-driven ECM remodeling and focal adhesion signaling associated with the transition from non-muscle-invasive to muscle-invasive bladder cancer.
Front Oncol2025https://conductscience.org/library/papers/41561769PubMed
40,427,211Active Surveillance in Non-Muscle Invasive Bladder Cancer: A Systematic Review.Cancers (Basel)2025https://conductscience.org/library/papers/40427211PubMed
39,497,708Deciphering the molecular heterogeneity of intermediate- and (very-)high-risk non-muscle-invasive bladder cancer using multi-layered -omics studies.Front Oncol2024https://conductscience.org/library/papers/39497708PubMed
38,769,130Preclinical models of bladder cancer: BBN and beyond.Nat Rev Urol2024https://conductscience.org/library/papers/38769130PubMed
37,774,064P53, CK20, and FGFR3 Overexpression is Associated with the Characteristics of Urothelial Cell Carcinoma of the BladderAsian Pac J Cancer Prev2023https://conductscience.org/library/papers/37774064PubMed
37,509,392Microtubule Dynamics Deregulation Induces Apoptosis in Human Urothelial Bladder Cancer Cells via a p53-Independent Pathway.Cancers (Basel)2023https://conductscience.org/library/papers/37509392PubMed
35,117,271The therapeutic and prognostic implications of molecular biomarkers in urothelial carcinoma.Transl Cancer Res2020https://conductscience.org/library/papers/35117271PubMed
35,071,023High Level of Aristolochic Acid Detected With a Unique Genomic Landscape Predicts Early UTUC Onset After Renal Transplantation in Taiwan.Front Oncol2021https://conductscience.org/library/papers/35071023PubMed
34,564,311Improvement of the Collection, Maintenance, and Analysis of Neoplastic Cells from Urine Specimens with the Use of CytoMatrix.Methods Protoc2021https://conductscience.org/library/papers/34564311PubMed
33,938,397The role of telomerase reverse transcriptase (TERT) promoter mutations in prognosis in bladder cancer.Bioengineered2021https://conductscience.org/library/papers/33938397PubMed

1 to 10 of 64

See all 64 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22158597

GET https://conductscience.org/api/papers/v1/22158597/references?page=2

API referenceFor AI assistants